News


OpenAI’s New Cybersecurity Model Tests the Path From Flaws to Fixes

GPT-6 Cyber expands AI-assisted vulnerability research, but OpenAI’s own findings show why validation and human oversight remain necessary.

After the Midterms, AI’s Next Bottleneck May Be Political

Democratic victories promise more scrutiny of AI companies and new pressure on the infrastructure behind them. For enterprise customers, the consequences could depend as much on where their suppliers build as on what Congress passes.

Enterprise AI Spending Surges, but Adoption Alone Does Not Explain the Bill

Enterprise AI spending is growing much faster than the number of businesses paying for it, according to new Menlo Ventures research that points to a shift from buying access for employees to financing work performed by agents.

AI Agents Are Moving Faster Than Enterprise Security Controls, Study Finds

Enterprises are deploying AI agents that can act within critical business applications, but security and governance controls are struggling to keep pace, according to new research from Delinea.

Anthropic’s IPO Filing Raises a Hard Question: How Much Can AI Safety Tests Prove?

Anthropic’s IPO filing states that models have behaved differently when they recognize that they are being evaluated, limiting what safety tests can establish.

Who Can Tell Anthropic to Stop? Its IPO Puts AI Safety Governance to the Test

Anthropic is preparing to sell shares to public investors while preserving a governance structure intended to let it pursue AI safety decisions that could conflict with financial returns.

Anthropic's IPO Tests Whether AI Demand Can Pay for the Infrastructure Behind It

Anthropic’s proposed initial public offering is bringing a central question in the AI industry into sharper view: whether revenue from customers can support the computing capacity providers are committing to buy years in advance.

AI Governance Lags as 84% of Organizations Report Issues, Delinea Finds

Among organizations using AI in critical business applications, 84% reported at least one AI-related issue in the past year, including incorrect financial transactions or actions that could not be traced or explained.

OpenAI Buys Orchestra Bio to Connect Scientific Research With Drug Development

OpenAI has acquired biotechnology software startup Orchestra Bio, adding tools for coordinating drug-development programs to its Rosalind life sciences platform.

Enterprise AI Buyers Demand Proof of ROI as Costs Mount, IDC Says

Nearly 70 percent of organizations report a significant gap between artificial intelligence spending and measurable financial returns, according to IDC research.

AI Returns Outpace Data Readiness and Oversight, Further Survey Finds

Businesses are reporting benefits from artificial intelligence even as their data preparation and oversight processes remain incomplete, according to a survey by data and AI services provider Further.

AI Agents Are Getting to Work. Who Insures Their Mistakes?

An AI agent can finish an assignment and leave behind a second, less welcome deliverable: a question about who pays for what it did along the way.

Featured